TTVL remained elevated 180 days post-transplant with a median (IQR) of 1.09×107 c/mL (3.24×105–1.03×108 c/mL) and 2.92×106 c/mL (9.88×104–5.89×107 c/mL) in the ATG and IL-2 RA group, respectively (P=0.242). The gene discussed is IL2; the disease is rheumatoid arthritis.